SIB 11.345,686 ANTEPROJETO DE DOUTORADO DIRETRIZES ABERTAS PARA CAPTAÇÃO DE FINANCIAMENTO.

 

O aspirante a admissibilidade no Doutorado em Toxicologia tem diversos livros virtuais e físicos indexados no Mecanismo Online para Referências. MORE é totalmente baseado na NBR 6023/2002, norma da ABNT atualmente em vigor. 1.9.12.2. O aspirante a admissibilidade no Doutorado em Toxicologia tem diversos livros virtuais e físicos indexados no Mecanismo Online para meuip Referências. MORE é totalmente baseado na NBR 6023/2002, norma da ABNT atualmente em vigor. http://ufsc.br/ - A Universidade Federal de Santa Catarina, é uma instituição de ensino superior pública brasileira, sendo a maior universidade do estado de Santa Catarina e uma das principais da Região Sul do Brasil. Está sediada em Florianópolis.

https://wwwdoutoradofarmacologiamedica.blogspot.com/2016/09/o-aspirante-admissibilidade-no.html

Bibliografia referencial em estudo analítico: Iatrogenia em cardiologia. REF 24.589.567.2021.

 

• 1. Auerback A, Gliebe PA. Iatrogenic heart disease: common cardiac neurosis. JAMA 1945; 129: 338-41.
• 2. Sevin BH. Mitral valve prolapse, panic states, and anxiety. Psychiatry Clin North Am 1987; 10: 141-150.
• 3. Wheeler EO, Williamson CR, Cohen ME. Heart scare, heart surveys, and iatrogenic heart disease: emotional and symptomatological effects of suggesting to one hundred sixty-two adults that they might have heart disease. JAMA 1958; 167: 1096-102.
• 4. Weinberg HB. Iatrogenic heart disease. Ann Intern Med 1953; 38: 9-22.
• 5. Melmon KL, Preventable drug reaction causes and cures semin. Med Beth Israel Hosp 1971; 284: 1361-7.
• 6. Rubin HA, Moskowitz MA. Complications of care in a medical intensive care unit. J Gen Intern Med 1990; 5: 104-09.
• 7. Serra AV. Doença iatrogęnica. Coimbra Med 1985; 4-5: 161-9.
• 8. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-84.
• 9
  Reducting errors in health care. Research in aviation, September 1998. Agency for Health Care Policy abd Research. Rockville, MD. http://wwwahcpr.gov/research/erros.htm
• 10. Singh BN, Collet JT, Chew CY. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis 1980; 93: 875-85.
• 11. Wooley RL. Antiarrhythimic drugs. Annu Rev Pharmacol Toxicol 1991; 31: 427-33.
• 12. Arnsdorf MF. Electrophysiologic properties of antidysrhythmic drugs as a rational basis for therapy. Med Clin North Am 1976; 60: 213-32.
• 13. Echt DS, Liebson PR, Mitchell B, et al. Mortality and morbidity in patients receiving ecainide flecainide or placebo the cardiac arrhythmia supression trial. N Engl J Med 1991; 324: 781-8.
• 14. Bedell SE, Deitz DC, Leeman D, et al. Incidence and characteristics of preventable iatrogenic cardiac arrest. JAMA 1991; 265: 2815-20.
• 15. The Fifth Report of the Joint National Committee on Detection, Education, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-83.
• 16. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997; 277: 739-45.
• 17. Smith ER, Smiseth AO, Kingma I, et al. Mechanism of action of nitrates. Role of changes in venous capacitance and in the left ventricular diastolic pressure volume relation. Am J Med 1984; 76: 14-21.
• 18. Murad F. Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers , and B- adrenergic antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Macmillan Publishing Co. Inc., 1979: 69-76.
• 19. Furberg CD, , et al. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31.
• 20. Cogan MG. Fluid and Electrolytes. Physiology and Pathophysiology - 3th ed. Stamford,Connecticut: Appleton & Lange 1991; 2: 20.
• 21. Thompson PL, Aylward PE, Federman J, et al. A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 h after recombinant tissue-type plasminogen activator for acute myocardial infarction.Circulation 1991; 83: 1534-42.
• 22. Cairns JS, , et al. Coronary thrombolysis. Chest 1995; 108: 401s.
• 23. The Digitalis Investigation Group. The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
• 24. Newton EH, Shih RD, Hoffman RS. Cyclic antidepressant overdose: A review of current management strategies. Am J Emerg Med 1994; 12: 376-82.
• 25. Dorr RT, Von Hoff DD. Cancer chemotherapy Handbook. 5th ed. (editors). Stamford, Connecticut: Appleton & Lange, 1994; 10: 21.
• 26. Lefevre F, Feruglas J, Pootts S, et al. Iatrogenic complications in high risk elderly patients. Arch Int Med 1992; 152: 2074-80.
• 27. Becker PM, McVey LJ, Satz CC, et al. Hospital acquired complication in randomized controlled clinical trial of a geriatric consultation team. JAMA 1987; 257: 2313-17.
• 28. Myer JD. Preventing iatrogenic complications. N Engl J Med 1981; 304: 664-5.
• 29. Taggart P, Carruthers M, Joseph S, and Somerville W. Electrocardiografic changes resembling myocardial ischaemia in asymptomatic men with normal coronary arteriograms. Br Heart J 1979; 42: 214-29.
• 30. Selzer A, Wray W. Quinidine syncope, aproxismal ventricular fibrillation occuring durng treatment of chronic atrial arrhythmias. Circulation 1964; 30: 17-26.
• 31. Keven A, Tzivoni D, Gavish D, et al. Warning signs and therapy of torsade de pointe. Circulation 1981; 64: 1167-74.
• 32. Zaret BL, Wackers FJ. Nuclear cardiology. N Engl J Med 1993; 329: 775-85.
• 33. Hart AD. Iatrogenics and cardiacs neurosis - Critique. Ann Intern Med 1953; 38: 9-22.
• 34. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: Implications for prevention. JAMA 1995; 274: 29-34.